Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy
NCT ID: NCT01112631
Last Updated: 2011-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
293 participants
OBSERVATIONAL
2003-04-30
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
NCT01279408
Perioperative Treatment Outcomes of Early NSCLC
NCT06610240
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
NCT06410300
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
NCT05292521
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
NCT02562027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stage II patients post surgery
Stage II patients treated with surgery alone
No interventions assigned to this group
Stage III patients post surgery
Stage III patients treated with surgery and PORT
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pN1 or pN2 disease,
* signed informed consent for participation in the study,
* Karnofsky Performance Status (KPS) higher than 70%.
Exclusion Criteria
* N2 diagnosed before surgery in imaging and/or mediastinoscopy,
* previous radiotherapy to the chest,
* no or inadequate mediastinal nodal dissection ,
* FEV1 after surgery lower than 1.0 liter,
* any active infectious process (including fistula formation) in the chest
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Tuberculosis and Lung Diseases in Warsaw
UNKNOWN
The Greater Poland Centre of Lung Diseases and Tuberculosis in Poznan
UNKNOWN
The Greater Poland Cancer Centre
OTHER
Cancer Centre in Bydgoszcz
UNKNOWN
Kujawsko-Pomorskie Center of Pulmonology in Bydgoszcz
UNKNOWN
Specialized Hospital in Zdunowo - Szczecin
UNKNOWN
Regional Cancer Hospital - Szczecin
UNKNOWN
Medical University of Gdansk
OTHER
Holycross Cancer Center in Kielce
UNKNOWN
Department of Thoracic Surgery - Wrocław
UNKNOWN
Department of Radiotherapy - Olsztyn
UNKNOWN
Department of Thoracic Surgery - Łódź
UNKNOWN
Lower Silesian Oncology Center - Wroclaw
UNKNOWN
Regional Specialized Hospital -Chęciny, Czerwona Góra
UNKNOWN
Department of Thoracic Surgery - Otwock
UNKNOWN
Medical University of Łódź
OTHER
Maria Sklodowska-Curie National Research Institute of Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology in Warsaw
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krzysztof Bujko, Prof.
Role: PRINCIPAL_INVESTIGATOR
Roentgena 5, 02-781 Warsaw, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M. Sklodowska-Curie Memorial Cancer Centre
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kepka L, Bujko K. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice]. Pneumonol Alergol Pol. 2007;75(3):256-61. Polish.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LPSG01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.